Use of MarginProbe® in DCIS Patients Presented at San Antonio Breast Cancer Symposium

[vc_row][vc_column][vc_column_text] MarginProbe use reduces re-excision surgeries in patients with diffuse disease Framingham, MA, December 8, 2011- An analysis of the MarginProbe pivotal study for patients with ductal carcinoma in situ (DCIS) and invasive lobular carcinoma (ILC) were presented today during the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The results were presented by Dr. Susan…

Read More

MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium

[vc_row][vc_column][vc_column_text] MarginProbe use reduces re-excision surgeries while conserving tissue Framingham, MA, December 7, 2011- Data from the MarginProbe system pivotal study were presented today during the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The results were presented by Dr. Freya Schnabel, Director of Breast Surgery, NYU Langone Medical Center, New York University, New York, New…

Read More